Urothelial carcinoma of an allograft ureter 10 years after deceased donor kidney transplantation

BMJ Case Reports
Kevin P GaughanPonnusamy Mohan

Abstract

The incidence of urothelial carcinoma (UC; formerly transitional cell carcinoma) is higher among renal transplant recipients compared with the general population. Upper urinary tract UC (UUT-UC) of allograft urothelium is a rare event with approximately 40 cases reported in the literature. Herein, we describe the clinical presentation and management of UUT-UC in a transplant ureter 10 years after deceased donor kidney transplantation.

References

Oct 11, 2002·Annals of Surgical Oncology·Francine TremblaySarkis Meterissian
May 29, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ming-Ju WuMing-Jer Tang
Dec 21, 2006·JAMA : the Journal of the American Medical Association·Claire M VajdicAndrew E Grulich
Jun 21, 2007·Transplantation Proceedings·N Basic-JukicI Juric
Dec 20, 2007·Transplantation Proceedings·H BakirtasM Eroglu
Aug 18, 2009·The Journal of Urology·Frank T D'ArcyDavid P Hickey
Dec 17, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Gustavo F FerreiraMiguel Srougi
Mar 18, 2011·Journal of Computer Assisted Tomography·Atul B ShinagareAnnick D Van den Abbeele
Jun 16, 2011·The Journal of Infectious Diseases·Ni LiMin Dai
Dec 12, 2012·Transplantation·Germaine WongJonathan C Craig
Jan 6, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J OlsburghG Koffman

❮ Previous
Next ❯

Citations

Sep 16, 2020·Virology Journal·Yigang ZengTongyu Zhu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.